Geneoscopy
US Patent Trial and Appeal Board to Review Exact Sciences Patent Contested by Geneoscopy
The appeal board determined that Geneoscopy has a "reasonable likelihood" of proving at least one claim the company had alleged in requesting the review.
Geneoscopy Countersues Exact Sciences Over Patent Central to Cologuard
Geneoscopy alleges that Exact Sciences has misappropriated its trade secrets, breached contract, and engaged in unfair competition.
Exact Sciences May Proceed With Patent Suit Against Geneoscopy, Court Rules
Exact Sciences alleges that Geneoscopy's ColoSense assay infringes upon patents covering Exact's Cologuard colorectal cancer assay.
People in the News at ERS Genomics, Enhanc3D Genomics, Zephyr AI, Geneoscopy, Seed Health
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Geneoscopy Nabs FDA Approval for Stool-Based Colorectal Cancer Screening Test
The St. Louis company's ColoSense assay is likely going to compete with Exact Sciences' Cologuard CRC screening test.